دورية أكاديمية

Clinical and economic impact of COVID-19 on people with obesity in a Spanish cohort during the first pandemic peak.

التفاصيل البيبلوغرافية
العنوان: Clinical and economic impact of COVID-19 on people with obesity in a Spanish cohort during the first pandemic peak.
المؤلفون: M., Torrego-Ellacuría, M. A., Rubio-Herrera, López-Valcárcel B., González, M. E., Fuentes-Ferrer, V., Martín, F., Poyato, P., Barber-Pérez, C., Santucci, A., Nuñez, C., González-Pérez, M., Luaces
المصدر: Frontiers in Endocrinology; 2023, p1-12, 12p
مصطلحات موضوعية: ECONOMIC impact, SPANIARDS, INTENSIVE care units, COVID-19 pandemic, COVID-19
مستخلص: Introduction: COVID-19 and obesity relationship has been extensively studied since the COVID-19 outbreak, proving obesity is a risk factor. This study aims to broaden the available information about this association and to evaluate the economic impact of obesity and the COVID-19 disease combination. Methods: This retrospective study analyzed a sample of 3,402 patients admitted to a Spanish hospital with available body mass index (BMI) data. Results: The prevalence of obesitywas 33.4%. Patients with obesity showed a higher risk of hospitalization (OR 95% ConfidenceInterval [CI]=1.46; [1.24-1.73]; p < 0.001), which increased with the obesity degree (I:OR [95%CI]=1.28 [1.06-1.55], p =0.010; II: OR [95% CI]=1.58 [1.16-2.15], p =0.004; III: OR [95% CI] =2.09 [1.31-3.34], p =0.002). Patients with type III obesity had a significantly higher risk of intensive care unit (ICU) admission (OR [95% CI]= 3.30 [1.67-6.53]; p = 0.001) and invasive mechanical ventilation (IMV) need (OR [95% CI]= 3.98 [2.00-7.94]; p<0.001). The average cost per patient was remarkably higher in patients with obesity (p = 0.007), reaching an excesscost of 28.41% in the studycohortandrising to56.5% in patients<70years. The average cost per patient increased significantly with the degree of obesity (p=0.007). Discussion: In conclusion, our results suggest a strong association between obesity and adverse COVID-19 outcomes and higher expenditures in patients with both conditions. [ABSTRACT FROM AUTHOR]
Copyright of Frontiers in Endocrinology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:16642392
DOI:10.3389/fendo.2023.1146517